glp-1 autoimmune Drugs: For Multiple Chronic Conditions GLP-1 and Inflammation: How These
Description
Saxagliptin: A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Streptozotocin Induced Alzheimers Disease
Published 2021
These medications have gained immense popularity for their effectiveness in managing weight and improving glycemic control
Can these agents prevent cardiometabolic disease in high-risk populations
